Tag: clinical trials
Understanding Adverse Event Rates: Percentages and Relative Risk in Clinical Trials
Adverse event rates in clinical trials must account for exposure time to avoid misleading safety conclusions. Learn how IR, EIR, and EAIR differ, why the FDA now requires exposure-adjusted methods, and how relative risk calculations impact drug safety assessments.
Ibrutinib’s Future in Cancer Research: Trends & Trials
Explore Ibrutinib's role in cancer research, its current uses, resistance challenges, next‑gen BTK inhibitors, and upcoming clinical trials shaping its future.
Amiloride for Diabetic Nephropathy: Mechanism, Evidence, and Clinical Guidance
Explore how amiloride works, the latest clinical evidence, dosing tips, and when it may benefit patients with diabetic kidney disease.